A NEPHROLOGIST’S VIEW TO RENAL SAFETY OF BISPHOSPHONATES

A NEPHROLOGIST’S VIEW TO RENAL SAFETY OF BISPHOSPHONATES

A variety of renal diseases and electrolyte disorders may be associated with malignancy or its treatment. The spectrum of disease in this setting includes acute renal failure (ARF), chronic renal failure, and tubular disorders.Chemotherapeutic agents as well as non-chemotherapeutic drugs can affect...

Full description

Bibliographic Details
Main Author:	Sevgi Şahin
Format:	Article
Language:	English
Published:	Galenos Publishing House 2007-07-01
Series:	European Journal of Breast Health
Subjects:	nephrotoxicity bisphosphonates malignancy
Online Access:	http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/a-nephrologsts-vew-to-renal-safety-of-bsphosphonat/42661

Similar Items

Malignant pilomatricoma in a dog with local and distant metastases treated with chemotherapy and bisphosphonates
by: Elisabetta Treggiari, et al.
Published: (2017-07-01)

An interesting case of bisphosphonate resistant hypercalcemia in acute myelogenous leukemia (AML)
by: Sara M. Cohen, et al.
Published: (2022-12-01)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
by: Emily Sunny Lee, et al.
Published: (2023-11-01)

Bisphosphonates
by: Fırat Öztürk
Published: (2009-04-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

BISPHOSPHONATE - RELATED MUCOSITIS (BRM): A CASE REPORT
by: Pavel Stanimirov, et al.
Published: (2017-03-01)

Thalassaemia: the dental implications of bisphosphonate therapy
by: Navdeep Kumar
Published: (2014-12-01)

Bisphosphonates: An update to the general dentist
by: Varun Dahiya, et al.
Published: (2013-01-01)

BISPHOSPHONATE INDUCED OSTEONECROSIS OF THE JAWS AND CURRENT THERAPIES
by: Damla Torul, et al.
Published: (2017-08-01)

Bases for the study of the safety of medicines. The spectrum of rare and unexpected ad-verse reactions of bisphosphonates
by: I S Dydykina, et al.
Published: (2011-12-01)

Bisphosphonate induced hypocalcaemia – report of six cases and review of the literature
by: Veronika Kreutle, et al.
Published: (2014-06-01)

Bisphosphonates: An update
by: Nalliappan Ganapathy, et al.
Published: (2012-01-01)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012-01-01)

Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013-01-01)

(2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone
by: Antonio Laghezza, et al.
Published: (2021-01-01)

BISPHOSPHONATE TREATMENT AND ESOPHAGEAL DISEASE
by: Andrei Evgenyevich Karateyev
Published: (2010-09-01)

Bisphosphonate-associated Osteonecrosis of the Jaws: a Survey of the Level of Knowledge of Dentists about the Risks of Bisphosphonate Therapy
by: Hristamyan-Cilev Meri A., et al.
Published: (2019-06-01)

BISPHOSPHONATE THERAPY IN PEDIATRIC PATIENTS WITH OSTEOGENESIS IMPERFECTA
by: Alina Murgu, et al.
Published: (2015-06-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
by: İlke Coşkun Benlidayı, et al.
Published: (2015-08-01)

Bisphosphonate - Related Osteonecrosis of the Jaw – Five Years Experience
by: Stilla J, et al.
Published: (2013-11-01)

6-Bromo-1-hydroxyhexane-1,1-bisphosphonic Acid Monosodium Salt
by: Petri A. Turhanen
Published: (2022-10-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

Patients' Awareness of the Complications of Bisphosphonate Therapy
by: Meri Hristamyan, et al.
Published: (2022-08-01)

Torus Palatinus Osteonecrosis Related to Bisphosphonate:A Case Report
by: Mariana Godinho, et al.
Published: (2013-04-01)

Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study
by: Simon Bishop, et al.
Published: (2023-09-01)

Is using Bisphosphonate a Contraindication for Dental Treatments?
by: Mohadese Heidari, et al.
Published: (2017-11-01)

Hypercalcemia of Malignancy: Clinical Characteristics and Treatment Outcome
by: Indra Wijaya, et al.
Published: (2014-06-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

The relationship between bisphosphonate use and demographic characteristics of male osteoporosis patients
by: Alev Cevikoi, et al.
Published: (2011-01-01)

Adherence to Bisphosphonates among People Admitted to an Orthopaedic and Geriatric Ward at a University Hospital in Sweden
by: Linnea Abramsson, et al.
Published: (2018-02-01)

Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking
by: Arezo TARDAST, et al.
Published: (2015-06-01)

Real‐world data for the renal safety of abemaciclib combined with bisphosphonate in HR+/HER2− advanced breast cancer
by: Chunfang Hao, et al.
Published: (2023-01-01)

Osseointegration of dental implants in patients with oral bisphosphonate intake: a review
by: Ali Moaddabi, et al.
Published: (2015-10-01)

The Effects of Various Food Products on Bisphosphonate’s Availability
by: Monika Zielińska, et al.
Published: (2022-03-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

Atypical femoral fractures related to bisphosphonate therapy
by: Tarun Pankaj Jain, et al.
Published: (2012-07-01)

Evaluation of trabecular bone changes according to the type of prosthesis in patients using bisphosphonates: a retrospective study
by: Begüm Ünlü Kurşun, et al.
Published: (2023-09-01)

Pharmacological therapy of osteoporosis with bisphosphonates – for whom, what kind, and for how long?
by: Ewa Marcinowska-Suchowierska, et al.
Published: (2014-09-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)